Acute Migraine Treatment Without IV Access in Urgent Care
For acute moderate to severe migraine in urgent care without IV access, start with oral combination therapy of a triptan (sumatriptan 100 mg or 50 mg) plus an NSAID (naproxen 500-825 mg or ibuprofen 400-800 mg), administered as early as possible after headache onset. 1
First-Line Oral Combination Therapy
The American College of Physicians recommends combination therapy with a triptan and an NSAID or acetaminophen as the most effective non-IV approach for moderate to severe migraine. 1 This provides superior efficacy compared to monotherapy and should be initiated immediately when pain is still mild if possible. 1, 2
Specific Dosing Recommendations
Oral Triptan Options:
- Sumatriptan 50-100 mg is the most studied and cost-effective option, with the 100 mg dose providing pain-free response in approximately 28% of patients at 2 hours (NNT 6.1) compared to 11% with placebo 3, 4
- The 50 mg dose offers the best balance of efficacy to tolerability, though many patients require and tolerate the 100 mg dose well 5
- Alternative triptans (rizatriptan, eletriptan, naratriptan, zolmitriptan) can be substituted based on individual response and cost 1
NSAID Component:
- Naproxen sodium 500-825 mg at onset, can repeat every 2-6 hours (maximum 1.5 g/day) 2
- Ibuprofen 400-800 mg is an acceptable alternative 2
- Limit NSAID use to <15 days per month to prevent medication overuse headache 6
Add Antiemetic for Enhanced Efficacy
Administer metoclopramide 10 mg orally or prochlorperazine 25 mg orally 20-30 minutes before the triptan-NSAID combination. 2 This provides synergistic analgesia beyond just treating nausea, as these dopamine antagonists have direct analgesic effects for migraine through central mechanisms. 2
Key Antiemetic Considerations:
- Metoclopramide and prochlorperazine are equally effective for migraine pain relief, not just nausea control 2
- Prochlorperazine has a more favorable side effect profile (21% adverse events vs 50% with chlorpromazine) 2
- Both should be limited to no more than twice weekly to prevent medication overuse headache 2
Alternative Non-Oral Routes When Oral Route Compromised
If significant nausea/vomiting prevents oral administration:
Intranasal Options:
- Sumatriptan nasal spray 20 mg (NNT 3.5 for headache relief at 2 hours) 7
- Zolmitriptan nasal spray 5 mg 2
- Intranasal administration provides faster onset than oral but slower than subcutaneous 7
Subcutaneous Option (if available in urgent care):
- Sumatriptan 6 mg subcutaneous is the most effective and rapidly acting option, providing pain-free response in 59% at 2 hours (NNT 2.3) with relief beginning within 15 minutes 2, 7
- This is the highest efficacy route but has higher adverse event rates 7
Rectal Option:
- Prochlorperazine 25 mg suppository for severe nausea 2
- Sumatriptan 25 mg rectal (NNT 2.4 for headache relief) if oral/intranasal routes fail 7
Second-Line Options for Treatment Failure
If the patient has already tried and failed adequate doses of triptan-NSAID combination:
CGRP Antagonists (Gepants):
- Rimegepant, ubrogepant, or zavegepant 1, 8
- These are appropriate when combination therapy provides inadequate response 1
Dihydroergotamine (DHE):
Critical Medications to AVOID
Never use opioids or butalbital-containing medications for acute migraine in urgent care. 1, 2 These lead to:
- Medication overuse headache and dependency 2
- Rebound headaches with increasing frequency 2
- Loss of efficacy over time 2
Medication Overuse Prevention
Limit all acute migraine treatments to no more than 2 days per week (or 10 days per month for triptans, 15 days per month for NSAIDs). 1, 6 Exceeding this frequency creates medication overuse headache, transforming episodic migraine into chronic daily headache. 1
If the patient requires acute treatment more frequently, they need preventive therapy rather than more frequent acute treatment. 6
Timing and Rescue Dosing
- Administer treatment as early as possible when pain is still mild for maximum efficacy 1, 3
- A second dose of triptan can be given if there was some response to the first dose, separated by at least 2 hours 3
- Maximum sumatriptan dose is 200 mg in 24 hours 3
- Additional rescue medication can be offered 4-24 hours after initial treatment for recurrent headache 3
Special Contraindications to Screen For
Before prescribing triptans, ensure the patient does NOT have: 3
- History of coronary artery disease or vasospasm
- Uncontrolled hypertension
- History of stroke or TIA
- Peripheral vascular disease
- Recent (within 24 hours) use of another triptan or ergot medication
- Recent (within 2 weeks) use of MAO inhibitor
- Severe hepatic impairment (maximum 50 mg sumatriptan if mild-moderate impairment) 3
When to Consider Preventive Therapy
If this patient has frequent migraines (≥2 days per month) or requires acute treatment more than twice weekly, they need preventive medication rather than relying solely on acute treatment. 6 This should be addressed at follow-up, not in the urgent care setting.